April 24, 2018
Science2Startup (S2S) is a one-day symposium on April 24, 2018 in Cambridge, MA co-organized by Atlas Venture, F-Prime Capital and SV Health Investors that will feature presentations and posters from top therapeutics researchers to a curated audience of experienced biotech venture capitalists, entrepreneurs at leading biotech startups, and senior executives at large pharma companies. Investigators from 40+ universities have presented their startup ideas at prior events, resulting in 13 companies receiving nearly $100 million in funding to date.
S2S is seeking proposals around novel therapeutic ideas. Submission can be made directly on their website, www.science2startup.com by December 15, 2017.
Opportunities that are less than 4 years from the clinic and have not received Series A funding are welcomed to participate. A legal entity or management team is NOT required. There is also not an upper limit on submission numbers per institution. Non-confidential decks are welcomed but not required. Proposals selected by the senior advisors will be notified in early December and there will be an opportunity to prepare/provide additional material. Further details regarding submissions and the review process are provided on the website, and you can read more about the event here.
Science2Startup is an invitation-only event for biotech entrepreneurship that aims to build connectivity across the academic, tech transfer, and venture capital communities. In addition to the presentations, the event will also feature panel discussions to help participants better navigate the startup process and a mentorship program to further refine their company strategy. Although the organizers are located in Massachusetts, they would like to see a geographic diversity in submissions.Learn more